acebutolol has been researched along with Alloxan Diabetes in 1 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The half-life in acute groups was significantly prolonged 8." | 1.32 | Pharmacokinetic changes of acebutolol after oral administration in rabbits with diabetes mellitus induced by alloxan. ( Bae, HY; Choi, DH; Choi, JS, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, DH | 1 |
| Bae, HY | 1 |
| Choi, JS | 1 |
1 other study available for acebutolol and Alloxan Diabetes
| Article | Year |
|---|---|
Pharmacokinetic changes of acebutolol after oral administration in rabbits with diabetes mellitus induced by alloxan.
Topics: Acebutolol; Administration, Oral; Animals; Diabetes Mellitus, Experimental; Rabbits | 2003 |